BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Radermecker C, Detrembleur N, Guiot J, Cavalier E, Henket M, d'Emal C, Vanwinge C, Cataldo D, Oury C, Delvenne P, Marichal T. Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J Exp Med 2020;217:e20201012. [PMID: 32926097 DOI: 10.1084/jem.20201012] [Cited by in Crossref: 95] [Cited by in F6Publishing: 151] [Article Influence: 47.5] [Reference Citation Analysis]
Number Citing Articles
1 Nishibori M. Novel aspects of sepsis pathophysiology: NETs, plasma glycoproteins, endotheliopathy and COVID-19. Journal of Pharmacological Sciences 2022;150:9-20. [DOI: 10.1016/j.jphs.2022.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xu X, Feng Y, Jia Y, Zhang X, Li L, Bai X, Jiao L. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis. Thromb Res 2022;218:83-98. [PMID: 36027630 DOI: 10.1016/j.thromres.2022.08.017] [Reference Citation Analysis]
3 Vahabi M, Ghazanfari T, Sepehrnia S. Molecular Mimicry, Hyperactive Immune System, And SARS-COV-2 Are Three Prerequisites of the Autoimmune Disease Triangle Following COVID-19 Infection. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.109183] [Reference Citation Analysis]
4 Aiello A, Grossi A, Meschi S, Meledandri M, Vanini V, Petrone L, Casetti R, Cuzzi G, Salmi A, Altera AM, Pierelli L, Gualano G, Ascoli Bartoli T, Castilletti C, Agrati C, Girardi E, Palmieri F, Nicastri E, Di Rosa E, Goletti D. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave. Front Immunol 2022;13:920227. [DOI: 10.3389/fimmu.2022.920227] [Reference Citation Analysis]
5 Janssen P, Tosi I, Hego A, Maréchal P, Marichal T, Radermecker C. Neutrophil Extracellular Traps Are Found in Bronchoalveolar Lavage Fluids of Horses With Severe Asthma and Correlate With Asthma Severity. Front Immunol 2022;13:921077. [DOI: 10.3389/fimmu.2022.921077] [Reference Citation Analysis]
6 Ventura-Santana E, Ninan JR, Snyder CM, Okeke EB. Neutrophil Extracellular Traps, Sepsis and COVID-19 - A Tripod Stand. Front Immunol 2022;13:902206. [PMID: 35757734 DOI: 10.3389/fimmu.2022.902206] [Reference Citation Analysis]
7 Moga E, Lynton-pons E, Domingo P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Front Immunol 2022;13:904686. [DOI: 10.3389/fimmu.2022.904686] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 McKenna E, Wubben R, Isaza-Correa JM, Melo AM, Mhaonaigh AU, Conlon N, O'Donnell JS, Ní Cheallaigh C, Hurley T, Stevenson NJ, Little MA, Molloy EJ. Neutrophils in COVID-19: Not Innocent Bystanders. Front Immunol 2022;13:864387. [PMID: 35720378 DOI: 10.3389/fimmu.2022.864387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Block H, Rossaint J, Zarbock A. The Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction. Cells 2022;11:1919. [PMID: 35741047 DOI: 10.3390/cells11121919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Legebeke J, Lord J, Penrice-Randal R, Vallejo AF, Poole S, Brendish NJ, Dong X, Hartley C, Holloway JW, Lucas JS, Williams AP, Wheway G, Strazzeri F, Gardner A, Schofield JPR, Skipp PJ, Hiscox JA, Polak ME, Clark TW, Baralle D. Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19. Front Immunol 2022;13:853265. [PMID: 35663963 DOI: 10.3389/fimmu.2022.853265] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Goldblatt D, Alter G, Crotty S, Plotkin SA. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol Rev 2022. [PMID: 35661178 DOI: 10.1111/imr.13091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Mcleish KR, Shrestha R, Vashishta A, Rane MJ, Barati MT, Brier ME, Lau MG, Hu X, Chen O, Wessel CR, Spalding T, Bush SE, Ijemere K, Hopkins CD, Cooke EA, Tandon S, Manning T, Uriarte SM, Huang J, Yan J. Differential Functional Responses of Neutrophil Subsets in Severe COVID-19 Patients. Front Immunol 2022;13:879686. [DOI: 10.3389/fimmu.2022.879686] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Eltobgy MM, Zani A, Kenney AD, Estfanous S, Kim E, Badr A, Carafice C, Daily K, Whitham O, Pietrzak M, Webb A, Kawahara J, Eddy AC, Denz P, Lu M, Kc M, Peeples ME, Li J, Zhu J, Que J, Robinson R, Rosas Mejia O, Rayner RE, Hall-Stoodley L, Seveau S, Gavrilin MA, Zhang X, Thomas J, Kohlmeier JE, Suthar MS, Oltz E, Tedeschi A, Robledo-Avila FH, Partida-Sanchez S, Hemann EA, Abdelrazik E, Forero A, Nimjee SM, Boyaka PN, Cormet-Boyaka E, Yount JS, Amer AO. Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis. Proc Natl Acad Sci U S A 2022;119:e2202012119. [PMID: 35588457 DOI: 10.1073/pnas.2202012119] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Liana P, Liberty IA, Murti K, Hafy Z, Salim EM, Zulkarnain M, Umar TP. A systematic review on neutrophil extracellular traps and its prognostication role in COVID-19 patients. Immunol Res 2022. [PMID: 35604493 DOI: 10.1007/s12026-022-09293-w] [Reference Citation Analysis]
15 Wang Z, Zhang Y, Yang R, Wang Y, Guo J, Sun R, Zhou Y, Su L, Ge Q, Feng Y. Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development. Front Immunol 2022;13:831194. [PMID: 35558069 DOI: 10.3389/fimmu.2022.831194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 D’amato M, Vertui V, Pandolfi L, Bozzini S, Fossali T, Colombo R, Aliberti A, Fumagalli M, Iadarola P, Didò C, Viglio S, Meloni F. Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients. CIMB 2022;44:2122-38. [DOI: 10.3390/cimb44050143] [Reference Citation Analysis]
17 Chavda V, Chaurasia B, Fiorindi A, Umana GE, Lu B, Montemurro N. Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities. Neurology International 2022;14:391-405. [DOI: 10.3390/neurolint14020032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
18 Zheng XS, Wang Q, Min J, Shen XR, Li Q, Zhao QC, Wang X, Jiang RD, Geng R, Chen Y, Zhu Y, Li B, Zhang W, Li A, Xie TT, Liu MQ, Cheng L, Shi ZL, Zhou P. Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection. J Virol 2022;:e0003822. [PMID: 35420442 DOI: 10.1128/jvi.00038-22] [Reference Citation Analysis]
19 Chan L, Morovati S, Karimi N, Alizadeh K, Vanderkamp S, Kakish JE, Bridle BW, Karimi K. Neutrophil Functional Heterogeneity and Implications for Viral Infections and Treatments. Cells 2022;11:1322. [DOI: 10.3390/cells11081322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Prével R, Dupont A, Labrouche-Colomer S, Garcia G, Dewitte A, Rauch A, Goutay J, Caplan M, Jozefowicz E, Lanoix JP, Poissy J, Rivière E, Orieux A, Malvy D, Gruson D, Garçon L, Susen S, James C. Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients. Front Immunol 2022;13:851497. [PMID: 35371025 DOI: 10.3389/fimmu.2022.851497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
21 Filep JG. Targeting Neutrophils for Promoting the Resolution of Inflammation. Front Immunol 2022;13:866747. [PMID: 35371088 DOI: 10.3389/fimmu.2022.866747] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Lu T, Zhang J, Cai J, Xiao J, Sui X, Yuan X, Li R, Li Y, Yao J, Lv G, Chen X, Chen H, Zeng K, Liu Y, Chen W, Chen G, Yang Y, Zheng J, Zhang Y. Extracellular vesicles derived from mesenchymal stromal cells as nanotherapeutics for liver ischaemia–reperfusion injury by transferring mitochondria to modulate the formation of neutrophil extracellular traps'. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Maggi E, Azzarone BG, Canonica GW, Moretta L. What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on the experience of allergic disorders. Allergy 2022;77:1114-28. [PMID: 34582050 DOI: 10.1111/all.15112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Paget C, Doz-deblauwe E, Winter N, Briard B. Specific NLRP3 Inflammasome Assembling and Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases. Cells 2022;11:1188. [DOI: 10.3390/cells11071188] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang Q, Ling S, Hu K, Liu J, Xu J. Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19). Biomedicine & Pharmacotherapy 2022;148:112718. [DOI: 10.1016/j.biopha.2022.112718] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wu T, Hsieh S, Li T, Lu C, Liao H, Shen C, Li K, Wu C, Kuo Y, Tsai C, Yu C. Molecular Basis for Paradoxical Activities of Polymorphonuclear Neutrophils in Inflammation/Anti-Inflammation, Bactericide/Autoimmunity, Pro-Cancer/Anticancer, and Antiviral Infection/SARS-CoV-II-Induced Immunothrombotic Dysregulation. Biomedicines 2022;10:773. [DOI: 10.3390/biomedicines10040773] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Temerozo JR, Sacramento CQ, Fintelman-Rodrigues N, Pão CRR, de Freitas CS, Dias SSG, Ferreira AC, Mattos M, Soares VC, Teixeira L, Azevedo-Quintanilha IG, Hottz ED, Kurtz P, Bozza FA, Bozza PT, Souza TML, Bou-Habib DC. VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells. J Leukoc Biol 2022. [PMID: 35322471 DOI: 10.1002/JLB.5COVA1121-626R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Wang J, Kotagiri P, Lyons PA, Al-Lamki RS, Mescia F, Bergamaschi L, Turner L, Morgan MD, Calero-Nieto FJ, Bach K, Mende N, Wilson NK, Watts ER, Maxwell PH, Chinnery PF, Kingston N, Papadia S, Stirrups KE, Walker N, Gupta RK, Menon DK, Allinson K, Aitken SJ, Toshner M, Weekes MP, Nathan JA, Walmsley SR, Ouwehand WH, Kasanicki M, Göttgens B, Marioni JC, Smith KGC, Pober JS, Bradley JR; Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) Covid BioResource Collaboration. Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19. iScience 2022;25:103971. [PMID: 35224470 DOI: 10.1016/j.isci.2022.103971] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Nappi F, Giacinto O, Ellouze O, Nenna A, Avtaar Singh SS, Chello M, Bouzguenda A, Copie X. Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. Biomedicines 2022;10:702. [DOI: 10.3390/biomedicines10030702] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Pastorek M, Dúbrava M, Celec P. On the Origin of Neutrophil Extracellular Traps in COVID-19. Front Immunol 2022;13:821007. [DOI: 10.3389/fimmu.2022.821007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Goncharov NV, Vasilyev KA, Kudryavtsev IV, Avdonin PP, Belinskaia DA, Stukova MA, Shamova OV, Avdonin PV. Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1). J Evol Biochem Phys 2022;58:230-46. [DOI: 10.1134/s0022093022010203] [Reference Citation Analysis]
32 d’Alessandro M, Conticini E, Bergantini L, Cameli P, Cantarini L, Frediani B, Bargagli E. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping Review. Life 2022;12:317. [DOI: 10.3390/life12020317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Wang H, Tumes DJ, Hercus TR, Yip KH, Aloe C, Vlahos R, Lopez AF, Wilson N, Owczarek CM, Bozinovski S. Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models. Cell Death Dis 2022;13:137. [PMID: 35145069 DOI: 10.1038/s41419-022-04589-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Cesta MC, Zippoli M, Marsiglia C, Gavioli EM, Mantelli F, Allegretti M, Balk RA. The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome. Front Pharmacol 2021;12:808797. [PMID: 35095519 DOI: 10.3389/fphar.2021.808797] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
35 Hasankhani A, Bahrami A, Sheybani N, Aria B, Hemati B, Fatehi F, Ghaem Maghami Farahani H, Javanmard G, Rezaee M, Kastelic JP, Barkema HW. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic. Front Immunol 2021;12:789317. [PMID: 34975885 DOI: 10.3389/fimmu.2021.789317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Alkattan W, Yaqinuddin A, Shafqat A, Kashir J. NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1741418] [Reference Citation Analysis]
37 Zhang Y, Wang Q, Mackay CR, Ng LG, Kwok I. Neutrophil subsets and their differential roles in viral respiratory diseases. J Leukoc Biol 2022. [PMID: 35040189 DOI: 10.1002/JLB.1MR1221-345R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Dechamps M, De Poortere J, Martin M, Gatto L, Daumerie A, Bouzin C, Octave M, Ginion A, Robaux V, Pirotton L, Bodart J, Gerard L, Montiel V, Campion A, Gruson D, Van Dievoet M, Douxfils J, Haguet H, Morimont L, Derive M, Jolly L, Bertrand L, Dumoutier L, Castanares-zapatero D, Laterre P, Horman S, Beauloye C. Inflammation-Induced Coagulopathy Substantially Differs Between COVID-19 and Septic Shock: A Prospective Observational Study. Front Med 2022;8:780750. [DOI: 10.3389/fmed.2021.780750] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Mairpady Shambat S, Gómez-Mejia A, Schweizer TA, Huemer M, Chang CC, Acevedo C, Bergada-Pijuan J, Vulin C, Hofmaenner DA, Scheier TC, Hertegonne S, Parietti E, Miroshnikova N, Wendel Garcia PD, Hilty MP, Buehler PK, Schuepbach RA, Brugger SD, Zinkernagel AS. Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19. PLoS Pathog 2022;18:e1010176. [PMID: 35007290 DOI: 10.1371/journal.ppat.1010176] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
40 Blanch-Ruiz MA, Ortega-Luna R, Gómez-García G, Martínez-Cuesta MÁ, Álvarez Á. Role of Neutrophil Extracellular Traps in COVID-19 Progression: An Insight for Effective Treatment. Biomedicines 2021;10:31. [PMID: 35052711 DOI: 10.3390/biomedicines10010031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
41 Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Meeus P, Bossuyt X, De Neve N, Van Hoovels L. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta 2021;525:54-61. [PMID: 34919937 DOI: 10.1016/j.cca.2021.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Schweizer TA, Mairpady Shambat S, Vulin C, Hoeller S, Acevedo C, Huemer M, Gomez‐mejia A, Chang C, Baum J, Hertegonne S, Hitz E, Scheier TC, Hofmaenner DA, Buehler PK, Moch H, Schuepbach RA, Brugger SD, Zinkernagel AS. Blunted sFasL signalling exacerbates TNF‐driven neutrophil necroptosis in critically ill COVID‐19 patients. Clin & Trans Imm 2021;10. [DOI: 10.1002/cti2.1357] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
43 Milross L, Majo J, Cooper N, Kaye PM, Bayraktar O, Filby A, Fisher AJ. Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19. Lancet Respir Med 2022;10:95-106. [PMID: 34871544 DOI: 10.1016/S2213-2600(21)00408-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
44 Lim J, Puan KJ, Wang LW, Teng KWW, Loh CY, Tan KP, Carissimo G, Chan YH, Poh CM, Lee CY, Fong SW, Yeo NK, Chee RS, Amrun SN, Chang ZW, Tay MZ, Torres-Ruesta A, Leo Fernandez N, How W, Andiappan AK, Lee W, Duan K, Tan SY, Yan G, Kalimuddin S, Lye DC, Leo YS, Ong SWX, Young BE, Renia L, Ng LFP, Lee B, Rötzschke O. Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals. Front Immunol 2021;12:710217. [PMID: 34867943 DOI: 10.3389/fimmu.2021.710217] [Reference Citation Analysis]
45 Borella R, De Biasi S, Paolini A, Boraldi F, Lo Tartaro D, Mattioli M, Fidanza L, Neroni A, Caro-Maldonado A, Meschiari M, Franceschini E, Quaglino D, Guaraldi G, Bertoldi C, Sita M, Busani S, Girardis M, Mussini C, Cossarizza A, Gibellini L. Metabolic reprograming shapes neutrophil functions in severe COVID-19. Eur J Immunol 2021. [PMID: 34870329 DOI: 10.1002/eji.202149481] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
46 Escobedo RA, Singh DK, Kaushal D. Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo. Front Immunol 2021;12:765349. [PMID: 34858417 DOI: 10.3389/fimmu.2021.765349] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
47 Wang LL, Yang JW, Xu JF. Coronavirus (SARS-CoV-2) causes lung inflammation and injury. Clin Microbiol Infect 2021:S1198-743X(21)00674-1. [PMID: 34861410 DOI: 10.1016/j.cmi.2021.11.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol 2021;164:69-82. [PMID: 34838588 DOI: 10.1016/j.yjmcc.2021.11.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
49 Poli V, Pui-Yan Ma V, Di Gioia M, Broggi A, Benamar M, Chen Q, Mazitschek R, Haggarty SJ, Chatila TA, Karp JM, Zanoni I. Zinc-dependent histone deacetylases drive neutrophil extracellular trap formation and potentiate local and systemic inflammation. iScience 2021;24:103256. [PMID: 34761180 DOI: 10.1016/j.isci.2021.103256] [Reference Citation Analysis]
50 Higashikuni Y, Liu W, Obana T, Sata M. Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications. Int J Mol Sci 2021;22:12081. [PMID: 34769508 DOI: 10.3390/ijms222112081] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
51 Qin G, Liu S, Yang L, Yu W, Zhang Y. Myeloid cells in COVID-19 microenvironment. Signal Transduct Target Ther 2021;6:372. [PMID: 34707085 DOI: 10.1038/s41392-021-00792-0] [Reference Citation Analysis]
52 Zhu R, Yan T, Feng Y, Liu Y, Cao H, Peng G, Yang Y, Xu Z, Liu J, Hou W, Wang X, Li Z, Deng L, Wang S, Li J, Han Q, Li H, Shan G, Cao Y, An X, Yan J, Zhang Z, Li H, Qu X, Zhu J, Zhou S, Wang J, Zhang F, Gao J, Jin R, Xu D, Ma YQ, Huang T, Peng S, Zheng Z, Stambler I, Gilson E, Lim LW, Moskalev A, Cano A, Chakrabarti S, Ulfhake B, Su H, Xu H, Xu S, Wei F, Brown-Borg HM, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms. Cell Res 2021. [PMID: 34702946 DOI: 10.1038/s41422-021-00573-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
53 Giacomelli C, Piccarducci R, Marchetti L, Romei C, Martini C. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients. Biochem Pharmacol 2021;193:114812. [PMID: 34687672 DOI: 10.1016/j.bcp.2021.114812] [Reference Citation Analysis]
54 Caillon A, Trimaille A, Favre J, Jesel L, Morel O, Kauffenstein G. Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID-19-associated thrombopathy. J Thromb Haemost 2021. [PMID: 34672094 DOI: 10.1111/jth.15566] [Reference Citation Analysis]
55 Hidalgo A, Libby P, Soehnlein O, Aramburu IV, Papayannopoulos V, Silvestre-Roig C. Neutrophil extracellular traps: from physiology to pathology. Cardiovasc Res 2021:cvab329. [PMID: 34648022 DOI: 10.1093/cvr/cvab329] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
56 Kyei-Barffour I, Addo SA, Aninagyei E, Ghartey-Kwansah G, Acheampong DO. Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative. Biomed Pharmacother 2021;144:112282. [PMID: 34624675 DOI: 10.1016/j.biopha.2021.112282] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
57 Spier AB, Evans CE. Emerging and Established Histological Techniques for the Analysis of Thrombosis in COVID-19 Lungs. Front Cardiovasc Med 2021;8:745906. [PMID: 34621804 DOI: 10.3389/fcvm.2021.745906] [Reference Citation Analysis]
58 Mun Y, Hwang JS, Shin YJ. Role of Neutrophils on the Ocular Surface. Int J Mol Sci 2021;22:10386. [PMID: 34638724 DOI: 10.3390/ijms221910386] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
59 Torres-Ruiz J, Absalón-Aguilar A, Nuñez-Aguirre M, Pérez-Fragoso A, Carrillo-Vázquez DA, Maravillas-Montero JL, Mejía-Domínguez NR, Llorente L, Alcalá-Carmona B, Lira-Luna J, Núñez-Álvarez C, Juárez-Vega G, Meza-Sánchez D, Hernández-Gilsoul T, Tapia-Rodríguez M, Gómez-Martín D. Neutrophil Extracellular Traps Contribute to COVID-19 Hyperinflammation and Humoral Autoimmunity. Cells 2021;10:2545. [PMID: 34685525 DOI: 10.3390/cells10102545] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
60 Alberca RW, Solis-Castro RL, Solis-Castro ME, Cardoso F, Duarte AJDS, Oliveira LM, Pereira NZ, Gozzi-Silva SC, Oliveira EA, Aoki V, Orfali RL, Beserra DR, Andrade MMS, Sato MN. Platelet-Based Biomarkers for Diagnosis and Prognosis in COVID-19 Patients. Life (Basel) 2021;11:1005. [PMID: 34685377 DOI: 10.3390/life11101005] [Reference Citation Analysis]
61 Radermecker C, Hego A, Delvenne P, Marichal T. Identification and Quantitation of Neutrophil Extracellular Traps in Human Tissue Sections. Bio Protoc 2021;11:e4159. [PMID: 34692909 DOI: 10.21769/BioProtoc.4159] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
62 Mol S, Hafkamp FMJ, Varela L, Simkhada N, Taanman-Kueter EW, Tas SW, Wauben MHM, Groot Kormelink T, de Jong EC. Efficient Neutrophil Activation Requires Two Simultaneous Activating Stimuli. Int J Mol Sci 2021;22:10106. [PMID: 34576270 DOI: 10.3390/ijms221810106] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
63 Christie MJ, Irving AT, Forster SC, Marsland BJ, Hansbro PM, Hertzog PJ, Nold-Petry CA, Nold MF. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection. Sci Immunol 2021;6:eabd0205. [PMID: 34533977 DOI: 10.1126/sciimmunol.abd0205] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
64 Bülow Anderberg S, Lipcsey M, Hultström M, Eriksson AK, Venge P, Frithiof R, On Behalf Of The Uppsala Intensive Care Covid-Research Group. Systemic Human Neutrophil Lipocalin Associates with Severe Acute Kidney Injury in SARS-CoV-2 Pneumonia. J Clin Med 2021;10:4144. [PMID: 34575252 DOI: 10.3390/jcm10184144] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
66 Oliva A, Rando E, Al Ismail D, De Angelis M, Cancelli F, Miele MC, Aronica R, Mauro V, Di Timoteo F, Loffredo L, Mastroianni CM. Role of Serum E-Selectin as a Biomarker of Infection Severity in Coronavirus Disease 2019. J Clin Med 2021;10:4018. [PMID: 34501466 DOI: 10.3390/jcm10174018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Kwiecień I, Rutkowska E, Kulik K, Kłos K, Plewka K, Raniszewska A, Rzepecki P, Chciałowski A. Neutrophil Maturation, Reactivity and Granularity Research Parameters to Characterize and Differentiate Convalescent Patients from Active SARS-CoV-2 Infection. Cells 2021;10:2332. [PMID: 34571981 DOI: 10.3390/cells10092332] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
68 Yaykasli KO, Schauer C, Muñoz LE, Mahajan A, Knopf J, Schett G, Herrmann M. Neutrophil Extracellular Trap-Driven Occlusive Diseases. Cells 2021;10:2208. [PMID: 34571857 DOI: 10.3390/cells10092208] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
69 Szturmowicz M, Demkow U. Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease. Int J Mol Sci 2021;22:8854. [PMID: 34445556 DOI: 10.3390/ijms22168854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
70 Fortini F, Vieceli Dalla Sega F, Marracino L, Severi P, Rapezzi C, Rizzo P, Ferrari R. Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape. Biomedicines 2021;9:997. [PMID: 34440201 DOI: 10.3390/biomedicines9080997] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
71 Sofias AM, De Lorenzi F, Peña Q, Azadkhah Shalmani A, Vucur M, Wang JW, Kiessling F, Shi Y, Consolino L, Storm G, Lammers T. Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. Adv Drug Deliv Rev 2021;175:113831. [PMID: 34139255 DOI: 10.1016/j.addr.2021.113831] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
72 Podstawka J, Sinha S, Hiroki CH, Sarden N, Granton E, Labit E, Kim JH, Andonegui G, Lou Y, Snarr BD, Sheppard DC, Rosin NL, Biernaskie J, Yipp BG. Marginating transitional B cells modulate neutrophils in the lung during inflammation and pneumonia. J Exp Med 2021;218:e20210409. [PMID: 34313733 DOI: 10.1084/jem.20210409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
73 Calado MB, da Silva Santana CE, Crovella S. Do inflammasome impact COVID-19 severity? Virusdisease 2021;:1-11. [PMID: 34337108 DOI: 10.1007/s13337-021-00705-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
74 Evans P, Wojta J, Hoefer IE, Waltenberger J, Guzik T, Badimon L, Weber C. The year in basic vascular biology research: from mechanoreceptors and neutrophil extracellular traps to smartphone data and omics. Cardiovasc Res 2021;117:1814-22. [PMID: 33744925 DOI: 10.1093/cvr/cvab105] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 de Oliveira M, De Sibio MT, Costa FAS, Sakalem ME. Airway and Alveoli Organoids as Valuable Research Tools in COVID-19. ACS Biomater Sci Eng 2021;7:3487-502. [PMID: 34288642 DOI: 10.1021/acsbiomaterials.1c00306] [Reference Citation Analysis]
76 Rawat S, Vrati S, Banerjee A. Neutrophils at the crossroads of acute viral infections and severity. Mol Aspects Med 2021;:100996. [PMID: 34284874 DOI: 10.1016/j.mam.2021.100996] [Reference Citation Analysis]
77 Andrianto, Al-Farabi MJ, Nugraha RA, Marsudi BA, Azmi Y. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis. Microvasc Res 2021;138:104224. [PMID: 34273359 DOI: 10.1016/j.mvr.2021.104224] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
78 Darcis G, Bouquegneau A, Maes N, Thys M, Henket M, Labye F, Rousseau AF, Canivet P, Desir C, Calmes D, Schils R, De Worm S, Léonard P, Meunier P, Moutschen M, Louis R, Guiot J. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. Int J Infect Dis 2021;109:209-16. [PMID: 34273510 DOI: 10.1016/j.ijid.2021.07.016] [Reference Citation Analysis]
79 Stacey HD, Golubeva D, Posca A, Ang JC, Novakowski KE, Zahoor MA, Kaushic C, Cairns E, Bowdish DME, Mullarkey CE, Miller MS. IgA potentiates NETosis in response to viral infection. Proc Natl Acad Sci U S A 2021;118:e2101497118. [PMID: 34183391 DOI: 10.1073/pnas.2101497118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
80 Subramaniam S, Ruf W, Bosmann M. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019. Br J Pharmacol 2021. [PMID: 34235728 DOI: 10.1111/bph.15587] [Reference Citation Analysis]
81 Park SH. An Impaired Inflammatory and Innate Immune Response in COVID-19. Mol Cells 2021;44:384-91. [PMID: 34098591 DOI: 10.14348/molcells.2021.0068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
82 Mozzini C, Pagani M. Cardiovascular Diseases: Consider Netosis. Curr Probl Cardiol 2021;:100929. [PMID: 34315622 DOI: 10.1016/j.cpcardiol.2021.100929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Semeraro N, Colucci M. The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects. Mediterr J Hematol Infect Dis 2021;13:e2021045. [PMID: 34276914 DOI: 10.4084/MJHID.2021.045] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
84 Fakhoury HMA, Kvietys PR, Shakir I, Shams H, Grant WB, Alkattan K. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D. Nutrients 2021;13:2216. [PMID: 34203190 DOI: 10.3390/nu13072216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
85 Kula BE, Clancy CJ, Hong Nguyen M, Schwartz IS. Invasive mould disease in fatal COVID-19: a systematic review of autopsies. Lancet Microbe 2021;2:e405-14. [PMID: 34189490 DOI: 10.1016/S2666-5247(21)00091-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
86 MacDonald L, Alivernini S, Tolusso B, Elmesmari A, Somma D, Perniola S, Paglionico A, Petricca L, Bosello SL, Carfì A, Sali M, Stigliano E, Cingolani A, Murri R, Arena V, Fantoni M, Antonelli M, Landi F, Franceschi F, Sanguinetti M, McInnes IB, McSharry C, Gasbarrini A, Otto TD, Kurowska-Stolarska M, Gremese E. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight 2021;6:147413. [PMID: 34143756 DOI: 10.1172/jci.insight.147413] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
87 Wilk AJ, Lee MJ, Wei B, Parks B, Pi R, Martínez-Colón GJ, Ranganath T, Zhao NQ, Taylor S, Becker W, Jimenez-Morales D, Blomkalns AL, O'Hara R, Ashley EA, Nadeau KC, Yang S, Holmes S, Rabinovitch M, Rogers AJ, Greenleaf WJ, Blish CA; Stanford COVID-19 Biobank. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. J Exp Med 2021;218:e20210582. [PMID: 34128959 DOI: 10.1084/jem.20210582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
88 Pandolfi L, Bozzini S, Frangipane V, Percivalle E, De Luigi A, Violatto MB, Lopez G, Gabanti E, Carsana L, D'Amato M, Morosini M, De Amici M, Nebuloni M, Fossali T, Colombo R, Saracino L, Codullo V, Gnecchi M, Bigini P, Baldanti F, Lilleri D, Meloni F. Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis. Front Immunol 2021;12:663303. [PMID: 34194429 DOI: 10.3389/fimmu.2021.663303] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
89 Morton B, Barnes KG, Anscombe C, Jere K, Matambo P, Mandolo J, Kamng'ona R, Brown C, Nyirenda J, Phiri T, Banda NP, Van Der Veer C, Mndolo KS, Mponda K, Rylance J, Phiri C, Mallewa J, Nyirenda M, Katha G, Kambiya P, Jafali J, Mwandumba HC, Gordon SB, Cornick J, Jambo KC; Blantyre COVID-19 Consortium. Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa. Nat Commun 2021;12:3554. [PMID: 34117221 DOI: 10.1038/s41467-021-23267-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Kvietys PR, Fakhoury HMA, Kadan S, Yaqinuddin A, Al-Mutairy E, Al-Kattan K. COVID-19: Lung-Centric Immunothrombosis. Front Cell Infect Microbiol 2021;11:679878. [PMID: 34178722 DOI: 10.3389/fcimb.2021.679878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
91 Tan Q, He L, Meng X, Wang W, Pan H, Yin W, Zhu T, Huang X, Shan H. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J Nanobiotechnology 2021;19:173. [PMID: 34112203 DOI: 10.1186/s12951-021-00926-0] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
92 Hazeldine J, Lord JM. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets. Front Immunol 2021;12:680134. [PMID: 34149717 DOI: 10.3389/fimmu.2021.680134] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
93 Ambardar SR, Hightower SL, Huprikar NA, Chung KK, Singhal A, Collen JF. Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic. J Clin Med 2021;10:2452. [PMID: 34205928 DOI: 10.3390/jcm10112452] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 32.0] [Reference Citation Analysis]
94 Masso-Silva JA, Moshensky A, Shin J, Olay J, Nilaad S, Advani I, Bojanowski CM, Crotty S, Li WT, Ongkeko WM, Singla S, Crotty Alexander LE. Chronic E-Cigarette Aerosol Inhalation Alters the Immune State of the Lungs and Increases ACE2 Expression, Raising Concern for Altered Response and Susceptibility to SARS-CoV-2. Front Physiol 2021;12:649604. [PMID: 34122126 DOI: 10.3389/fphys.2021.649604] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
95 Ouwendijk WJD, Raadsen MP, van Kampen JJA, Verdijk RM, von der Thusen JH, Guo L, Hoek RAS, van den Akker JPC, Endeman H, Langerak T, Molenkamp R, Gommers D, Koopmans MPG, van Gorp ECM, Verjans GMGM, Haagmans BL. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019. J Infect Dis 2021;223:1512-21. [PMID: 33507309 DOI: 10.1093/infdis/jiab050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
96 Iovino L, Thur LA, Gnjatic S, Chapuis A, Milano F, Hill JA. Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy. J Immunother Cancer 2021;9:e002392. [PMID: 33986127 DOI: 10.1136/jitc-2021-002392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
97 Reyes L, A Sanchez-Garcia M, Morrison T, Howden AJM, Watts ER, Arienti S, Sadiku P, Coelho P, Mirchandani AS, Zhang A, Hope D, Clark SK, Singleton J, Johnston S, Grecian R, Poon A, McNamara S, Harper I, Fourman MH, Brenes AJ, Pathak S, Lloyd A, Blanco GR, von Kriegsheim A, Ghesquiere B, Vermaelen W, Cologna CT, Dhaliwal K, Hirani N, Dockrell DH, Whyte MKB, Griffith D, Cantrell DA, Walmsley SR. -------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--. Wellcome Open Res 2021;6:38. [PMID: 33997298 DOI: 10.12688/wellcomeopenres.16584.2] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
98 Cardoso EOC, Fine N, Glogauer M, Johnson F, Goldberg M, Golub LM, Tenenbaum HC. The Advent of COVID-19; Periodontal Research Has Identified Therapeutic Targets for Severe Respiratory Disease; an Example of Parallel Biomedical Research Agendas. Front Dent Med 2021;2:674056. [DOI: 10.3389/fdmed.2021.674056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Gremese E, Alivernini S, Ferraccioli G. RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection. Proc Natl Acad Sci U S A 2021;118:e2025609118. [PMID: 33975949 DOI: 10.1073/pnas.2025609118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Khezri MR, Zolbanin NM, Ghasemnejad-Berenji M, Jafari R. Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection. Eur J Pharmacol 2021;905:174191. [PMID: 34015317 DOI: 10.1016/j.ejphar.2021.174191] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Masso-Silva JA, Moshensky A, Lam MTY, Odish M, Patel A, Xu L, Hansen E, Trescott S, Nguyen C, Kim R, Perofsky K, Perera S, Ma L, Pham J, Rolfsen M, Olay J, Shin J, Dan JM, Abbott R, Ramirez S, Alexander TH, Lin GY, Fuentes AL, Advani I, Gunge D, Pretorius V, Malhotra A, Sun X, Duran J, Hepokoski M, Crotty S, Coufal NG, Meier A, Alexander LEC. Increased peripheral blood neutrophil activation phenotypes and NETosis in critically ill COVID-19 patients: a case series and review of the literature. Clin Infect Dis 2021:ciab437. [PMID: 33988226 DOI: 10.1093/cid/ciab437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
102 Morrissey SM, Geller AE, Hu X, Tieri D, Ding C, Klaes CK, Cooke EA, Woeste MR, Martin ZC, Chen O, Bush SE, Zhang HG, Cavallazzi R, Clifford SP, Chen J, Ghare S, Barve SS, Cai L, Kong M, Rouchka EC, McLeish KR, Uriarte SM, Watson CT, Huang J, Yan J. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients. JCI Insight 2021;6:148435. [PMID: 33986193 DOI: 10.1172/jci.insight.148435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
103 Yoshida M, Miyahara Y, Orimo K, Kono N, Narita M, Ohya Y, Matsumoto K, Nakagawa S, Ueki S, Morita H, Miyairi I. Eosinophil Extracellular Traps in the Casts of Plastic Bronchitis Associated With Influenza Virus Infection. Chest 2021:S0012-3692(21)00884-9. [PMID: 33971146 DOI: 10.1016/j.chest.2021.05.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Ramos SG, Rattis BADC, Ottaviani G, Celes MRN, Dias EP. ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients. Am J Pathol 2021;191:1154-64. [PMID: 33964216 DOI: 10.1016/j.ajpath.2021.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
105 Delaveris CS, Wilk AJ, Riley NM, Stark JC, Yang SS, Rogers AJ, Ranganath T, Nadeau KC, Blish CA, Bertozzi CR; Stanford COVID-19 Biobank. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19. ACS Cent Sci 2021;7:650-7. [PMID: 34056095 DOI: 10.1021/acscentsci.0c01669] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
106 Roongta R, Chattopadhyay A, Ghosh A. Correspondence on 'Onset of rheumatoid arthritis after COVID-19: coincidence or connected?'. Ann Rheum Dis 2021:annrheumdis-2021-220479. [PMID: 33906857 DOI: 10.1136/annrheumdis-2021-220479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
107 Feldman C, Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia (Nathan) 2021;13:5. [PMID: 33894790 DOI: 10.1186/s41479-021-00083-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 62] [Article Influence: 8.0] [Reference Citation Analysis]
108 Liu X, Zaid A, Freitas JR, McMillan NA, Mahalingam S, Taylor A. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice. mBio 2021;12:e00819-21. [PMID: 33879586 DOI: 10.1128/mBio.00819-21] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
109 Frija-Masson J, Bancal C, Plantier L, Benzaquen H, Mangin L, Penaud D, Arnoult F, Flamant M, d'Ortho MP. Alteration of Diffusion Capacity After SARS-CoV-2 Infection: A Pathophysiological Approach. Front Physiol 2021;12:624062. [PMID: 33841169 DOI: 10.3389/fphys.2021.624062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
110 Mahler M, Meroni PL, Infantino M, Buhler KA, Fritzler MJ. Circulating Calprotectin as a Biomarker of COVID-19 Severity. Expert Rev Clin Immunol 2021;17:431-43. [PMID: 33750254 DOI: 10.1080/1744666X.2021.1905526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
111 Petito E, Falcinelli E, Paliani U, Cesari E, Vaudo G, Sebastiano M, Cerotto V, Guglielmini G, Gori F, Malvestiti M, Becattini C, Paciullo F, De Robertis E, Bury L, Lazzarini T, Gresele P; COVIR study investigators. Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019. J Infect Dis 2021;223:933-44. [PMID: 33280009 DOI: 10.1093/infdis/jiaa756] [Cited by in Crossref: 25] [Cited by in F6Publishing: 52] [Article Influence: 25.0] [Reference Citation Analysis]
112 Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 2021;21:319-29. [PMID: 33824483 DOI: 10.1038/s41577-021-00536-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 207] [Article Influence: 33.0] [Reference Citation Analysis]
113 Easty DJ, Farr CJ, Hennessy BT. New Roles for Vitamin D Superagonists: From COVID to Cancer. Front Endocrinol (Lausanne) 2021;12:644298. [PMID: 33868174 DOI: 10.3389/fendo.2021.644298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Sessa F, Salerno M, Pomara C. Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2). Medicina (Kaunas) 2021;57:309. [PMID: 33806100 DOI: 10.3390/medicina57040309] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
115 Nishibori M, Stonestreet BS. Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins. Front Immunol 2021;12:656099. [PMID: 33841442 DOI: 10.3389/fimmu.2021.656099] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Oury C, Wéra O. P2X1: a unique platelet receptor with a key role in thromboinflammation. Platelets 2021;32:902-8. [PMID: 33760688 DOI: 10.1080/09537104.2021.1902972] [Reference Citation Analysis]
117 Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Moreno E, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Blair RV, Roy CJ, Smith N, Hall JM, Tomera KM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Front Pharmacol 2021;12:633680. [PMID: 33833683 DOI: 10.3389/fphar.2021.633680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
118 Dimbath E, Maddipati V, Stahl J, Sewell K, Domire Z, George S, Vahdati A. Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review. Life Sci 2021;274:119341. [PMID: 33716059 DOI: 10.1016/j.lfs.2021.119341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
119 Najm A, Alunno A, Mariette X, Terrier B, De Marco G, Emmel J, Mason L, McGonagle DG, Machado PM. Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider. RMD Open 2021;7:e001549. [PMID: 33574116 DOI: 10.1136/rmdopen-2020-001549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
120 Kaptein FHJ, Stals MAM, Huisman MV, Klok FA. Prophylaxis and treatment of COVID-19 related venous thromboembolism. Postgrad Med 2021;133:27-35. [PMID: 33657964 DOI: 10.1080/00325481.2021.1891788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
121 Zhu A, Chen Z, Wang Y, Zeng Q, Sun J, Zhuang Z, Li F, Zhao J, Zhao J, Zhong N. Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice. Fundamental Research 2021;1:124-30. [DOI: 10.1016/j.fmre.2021.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
122 Antoniak S, Mackman N. Platelets and viruses. Platelets 2021;32:325-30. [PMID: 33615982 DOI: 10.1080/09537104.2021.1887842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
123 Morton B, Barnes KG, Anscombe C, Jere K, Kamng'ona R, Brown C, Nyirenda J, Phiri T, Banda N, Van Der Veer C, Mndolo KS, Mponda K, Rylance J, Phiri C, Mallewa J, Nyirenda M, Katha G, Kambiya P, Jafali J, Mwandumba HC, Gordon SB, Cornick J, Jambo KC. In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profiles. medRxiv 2021:2021. [PMID: 33619502 DOI: 10.1101/2021.02.15.21251753] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 de Buhr N, von Köckritz-Blickwede M. The Balance of Neutrophil Extracellular Trap Formation and Nuclease Degradation: an Unknown Role of Bacterial Coinfections in COVID-19 Patients? mBio 2021;12:e03304-20. [PMID: 33593982 DOI: 10.1128/mBio.03304-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
125 Niu C, Du Y, Kaltashov IA. Towards better understanding of the heparin role in NETosis: feasibility of using native mass spectrometry to monitor interactions of neutrophil elastase with heparin oligomers. Int J Mass Spectrom 2021;463:116550. [PMID: 33692650 DOI: 10.1016/j.ijms.2021.116550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Fratta Pasini AM, Stranieri C, Cominacini L, Mozzini C. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications. Antioxidants (Basel) 2021;10:272. [PMID: 33578849 DOI: 10.3390/antiox10020272] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 25.0] [Reference Citation Analysis]
127 Clancy CJ, Schwartz IS, Kula B, Nguyen MH. Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies. Open Forum Infect Dis 2021;8:ofab065. [PMID: 33732753 DOI: 10.1093/ofid/ofab065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
128 Roberts J, Pritchard AL, Treweeke AT, Rossi AG, Brace N, Cahill P, MacRury SM, Wei J, Megson IL. Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System. Front Cardiovasc Med 2020;7:629933. [PMID: 33614744 DOI: 10.3389/fcvm.2020.629933] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
129 Ondracek AS, Lang IM. Neutrophil Extracellular Traps as Prognostic Markers in COVID-19: A Welcome Piece to the Puzzle. Arterioscler Thromb Vasc Biol 2021;41:995-8. [PMID: 33955780 DOI: 10.1161/ATVBAHA.120.315633] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
130 Latreille E, Lee WL. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy. Viruses. 2021;13. [PMID: 33499234 DOI: 10.3390/v13020161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
131 Janiuk K, Jabłońska E, Garley M. Significance of NETs Formation in COVID-19. Cells 2021;10:151. [PMID: 33466589 DOI: 10.3390/cells10010151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
132 Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 2021;184:861-80. [PMID: 33497610 DOI: 10.1016/j.cell.2021.01.007] [Cited by in Crossref: 172] [Cited by in F6Publishing: 178] [Article Influence: 172.0] [Reference Citation Analysis]
133 Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, Grifoni A, Ramirez SI, Haupt S, Frazier A, Nakao C, Rayaprolu V, Rawlings SA, Peters B, Krammer F, Simon V, Saphire EO, Smith DM, Weiskopf D, Sette A, Crotty S. Immunological memory to SARS-CoV-2 assessed for up to 8 mo after infection. Science. 2021;371. [PMID: 33408181 DOI: 10.1126/science.abf4063] [Cited by in Crossref: 527] [Cited by in F6Publishing: 1057] [Article Influence: 527.0] [Reference Citation Analysis]
134 Hofman P, Copin MC, Tauziede-Espariat A, Adle-Biassette H, Fortarezza F, Passeron T, Salmon I, Calabrese F. [Histopathological features due to the SARS-CoV-2]. Ann Pathol 2021;41:9-22. [PMID: 33446414 DOI: 10.1016/j.annpat.2020.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Timpani CA, Rybalka E. Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19. Pharmaceuticals (Basel) 2020;14:15. [PMID: 33375288 DOI: 10.3390/ph14010015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
136 Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res 2021;232:13-36. [PMID: 33352298 DOI: 10.1016/j.trsl.2020.12.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
137 Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, Grifoni A, Ramirez SI, Haupt S, Frazier A, Nakao C, Rayaprolu V, Rawlings SA, Peters B, Krammer F, Simon V, Saphire EO, Smith DM, Weiskopf D, Sette A, Crotty S. Immunological memory to SARS-CoV-2 assessed for up to eight months after infection. bioRxiv 2020:2020. [PMID: 33442687 DOI: 10.1101/2020.11.15.383323] [Cited by in Crossref: 61] [Cited by in F6Publishing: 16] [Article Influence: 30.5] [Reference Citation Analysis]
138 Delaveris CS, Wilk AJ, Riley NM, Stark JC, Yang SS, Rogers AJ, Ranganath T, Nadeau KC, Blish CA, Bertozzi CR; Stanford COVID-19 Biobank. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19. ChemRxiv 2020. [PMID: 33469569 DOI: 10.26434/chemrxiv.13378148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Matthay MA, Leligdowicz A, Liu KD. Biological Mechanisms of COVID-19 Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2020;202:1489-91. [PMID: 32997945 DOI: 10.1164/rccm.202009-3629ED] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
140 Ng H, Havervall S, Rosell A, Aguilera K, Parv K, von Meijenfeldt FA, Lisman T, Mackman N, Thålin C, Phillipson M. Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. Arterioscler Thromb Vasc Biol 2021;41:988-94. [PMID: 33267662 DOI: 10.1161/ATVBAHA.120.315267] [Cited by in Crossref: 18] [Cited by in F6Publishing: 66] [Article Influence: 9.0] [Reference Citation Analysis]
141 Yang J, Wu Z, Long Q, Huang J, Hong T, Liu W, Lin J. Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13. Front Immunol 2020;11:610696. [PMID: 33343584 DOI: 10.3389/fimmu.2020.610696] [Cited by in Crossref: 6] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
142 Lu L, Zhang H, Zhan M, Jiang J, Yin H, Dauphars DJ, Li SY, Li Y, He YW. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? Sci China Life Sci 2020;63:1833-49. [PMID: 33355886 DOI: 10.1007/s11427-020-1859-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
143 Cavalcante-Silva LHA, Carvalho DCM, Lima ÉA, Galvão JGFM, da Silva JSF, Sales-Neto JM, Rodrigues-Mascarenhas S. Neutrophils and COVID-19: The road so far. Int Immunopharmacol 2021;90:107233. [PMID: 33290963 DOI: 10.1016/j.intimp.2020.107233] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
144 Maxwell AJ, Ding J, You Y, Dong Z, Chehade H, Alvero A, Mor Y, Draghici S, Mor G. Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients. J Leukoc Biol 2021;109:35-47. [PMID: 33242368 DOI: 10.1002/JLB.4COVR0920-552RR] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
145 Gallo O, Locatello LG, Mazzoni A, Novelli L, Annunziato F. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection. Mucosal Immunol 2021;14:305-16. [PMID: 33244161 DOI: 10.1038/s41385-020-00359-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 70] [Article Influence: 14.5] [Reference Citation Analysis]
146 Mojoli A, Gonçalves BS, Temerozo JR, Cister-Alves B, Geddes V, Herlinger A, Aguiar RS, Pilotto JH, Saraiva EM, Bou-Habib DC. Neutrophil extracellular traps from healthy donors and HIV-1-infected individuals restrict HIV-1 production in macrophages. Sci Rep 2020;10:19603. [PMID: 33177532 DOI: 10.1038/s41598-020-75357-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
147 Kumar V. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19? Int Rev Immunol 2021;40:72-107. [PMID: 33155525 DOI: 10.1080/08830185.2020.1840567] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
148 Zuo Y, Zuo M, Yalavarthi S, Gockman K, Madison JA, Shi H, Woodard W, Lezak SP, Lugogo NL, Knight JS, Kanthi Y. Neutrophil extracellular traps and thrombosis in COVID-19. J Thromb Thrombolysis 2021;51:446-53. [PMID: 33151461 DOI: 10.1007/s11239-020-02324-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 96] [Article Influence: 13.5] [Reference Citation Analysis]
149 Francescangeli F, De Angelis ML, Baiocchi M, Rossi R, Biffoni M, Zeuner A. COVID-19-Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse? Front Oncol 2020;10:592891. [PMID: 33194755 DOI: 10.3389/fonc.2020.592891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
150 Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17:46-64. [PMID: 33077917 DOI: 10.1038/s41581-020-00357-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 192] [Article Influence: 42.5] [Reference Citation Analysis]
151 Elbadawi A, Elgendy IY, Sahai A, Bhandari R, McCarthy M, Gomes M, Bishop GJ, Bartholomew JR, Kapadia S, Cameron SJ. Incidence and Outcomes of Thrombotic Events in Symptomatic Patients With COVID-19. Arterioscler Thromb Vasc Biol 2021;41:545-7. [PMID: 32990453 DOI: 10.1161/ATVBAHA.120.315304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
152 [DOI: 10.1101/2020.12.18.423363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]